-
3221“…RESULTS: A total of 170 cases of singleton pregnant women with gestational age between 28–34 weeks suffering from PROM during January 1998 to December 2009 were included; 119 cases received prophylactic antibiotics and antenatal corticosteroids while 51 cases did not received prophylactic antibiotics and antenatal corticosteroids. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3222por Cöster, Maria C, Bremander, Ann, Rosengren, Björn E, Magnusson, Håkan, Carlsson, Åke, Karlsson, Magnus K“…SEFAS is therefore an appropriate patient- reported outcome measure (PROM) for these patients, even in national registries.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3223por Ribeiro, Henrique Barbosa, Sarmento-Leite, Rogério, Siqueira, Dimytri A. A., Carvalho, Luiz Antônio, Mangione, José Armando, Rodés-Cabau, Josep, Perin, Marco A., de Brito, Fábio Sandoli“…All patients were women, without prior coronary artery bypass grafting (CABG), and with mean age of 85 ± 3 years, logistic EuroSCORE of 15 ± 6% and STS-PROM score of 9 ± 4%. All of the cases were performed with balloon-expandable Sapien XT prosthesis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3224por Niskakoski, Anni, Kaur, Sippy, Staff, Synnöve, Renkonen-Sinisalo, Laura, Lassus, Heini, Järvinen, Heikki J, Mecklin, Jukka-Pekka, Bützow, Ralf, Peltomäki, Päivi“…In conclusion, we provide evidence of a frequent epigenetic inactivation of RSK4, SPARC, PROM1, HOXA10, HOXA9, WT1-AS, SFRP2, SFRP5, OPCML, and MIR34B in the development of non-serous ovarian carcinomas of Lynch and sporadic origin, as compared to serous tumors. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3225por Neska, Jacek, Swoboda, Paweł, Przybyszewska, Małgorzata, Kotlarz, Agnieszka, Bolla, Narasimha Rao, Miłoszewska, Joanna, Grygorowicz, Monika Anna, Kutner, Andrzej, Markowicz, Sergiusz“…All of the tested analogues of 1,25D2 equally potently decreased the clonogenicity and the proliferative activity of HT-29 cells which survived the exposure to 5-FU, but differently regulated gene expression of these cells during their renewal. 1,25D2 and analogues (PRI-1907 and PRI-1917), as well as 1,25D3 and analogue PRI-2191, decreased the relative expression level of several stemness-related genes, such as NANOG, OCT3/4, PROM1, SOX2, ALDHA1, CXCR4, in HT-29/5-FU cells during their renewal, in comparison to untreated HT-29/5-FU cells. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3226por Habibi, Imen, Chebil, Ahmed, Falfoul, Yosra, Allaman-Pillet, Nathalie, Kort, Fedra, Schorderet, Daniel F., El Matri, Leila“…The other changes detected were six previously reported mutations in CNGB3 (p.R203*), ABCA4 (p.W782*), NR2E3 (p.R311Q), RPE65 (p.H182Y), PROM1 (c.1354dupT) and EYS (c.5928-2A > G). Segregation analysis in each family showed that all affected individuals were homozygotes and unaffected individuals were either heterozygote carriers or homozygous wild type allele. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3227por Bogaerts, Eliene, Paridaens, Annelies, Verhelst, Xavier, Carmeliet, Peter, Geerts, Anja, Van Vlierberghe, Hans, Devisscher, Lindsey“…The mRNA expression of Afp and Epcam was increased at all time points following DEN whereas CK19, Prom1 and Notch3 were increased after 17 weeks of DEN, without difference between PHD2(+/-) and WT mice. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3228por Martin, Glen P., Sperrin, Matthew, Ludman, Peter F., de Belder, Mark A., Gale, Chris P., Toff, William D., Moat, Neil E., Trivedi, Uday, Buchan, Iain, Mamas, Mamas A.“…This study aimed to investigate the performance of the German Aortic Valve, FRANCE-2, OBSERVANT and American College of Cardiology (ACC) TAVI CPMs compared with the performance of historic cardiac CPMs such as the EuroSCORE and STS-PROM, in a large national TAVI registry. METHODS: The calibration and discrimination of each CPM were analyzed in 6676 patients from the UK TAVI registry, as a whole cohort and across several subgroups. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3229por Littauer, Elizabeth Q., Esser, E. Stein, Antao, Olivia Q., Vassilieva, Elena V., Compans, Richard W., Skountzou, Ioanna“…Severity of infection during pregnancy was correlated with premature rupture of amniotic membranes (PROM), fetal survival and body weight at birth, lung viral load and degree of systemic and tissue inflammation mediated by innate and adaptive immune responses. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3230por Birtel, Johannes, Eisenberger, Tobias, Gliem, Martin, Müller, Philipp L., Herrmann, Philipp, Betz, Christian, Zahnleiter, Diana, Neuhaus, Christine, Lenzner, Steffen, Holz, Frank G., Mangold, Elisabeth, Bolz, Hanno J., Charbel Issa, Peter“…Further mutations were identified in CDHR1, GUCY2D, PROM1, CRX, GUCA1A, CERKL, MT-TL1, KIF11, RP1L1, MERTK, RDH5, CDH3, C1QTNF5, CRB1, JAG1, DRAM2, POC1B, NPHP1 and RPGR. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3231por Bhatt, Nikita R., Breen, Kieran, Haroon, Usman M., Akram, Muhammad, Flood, Hugh D., Giri, Subhasis K.“…MATERIAL AND METHODS: We retrospectively utilised the Patient Reported Outcome Methods (PROM) tool validated for TRUSPB and the International Index of Erectile Function (IIEF-5) questionnaire to collect longitudinal data at follow-up in the same cohort of patients who underwent both TTPB and TRUSPB between January 2015 and February 2016. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3232por de Vroege, Lars, Emons, Wilco H. M., Sijtsma, Klaas, van der Feltz-Cornelis, Christina M.“…Second, we explored treatment outcomes of a multimodal treatment tailored to patient needs by Shared Decision Making (SDM) and Patient Related Outcome Monitoring (PROM) in patients with SSRD. Third, we explored whether alexithymia is associated with treatment outcome. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3233por Peilot, Birgitta, Andréll, Paulin, Gottfries, Johan, Sundler, Annelie J., Mannheimer, Clas“…Patient reported outcome measures (PROM) were administered at baseline and at follow-up after 8 months. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3234por Alfarwati, Tariq W., Alamri, Abdullah A., Alshahrani, Mubarak A., Al-Wassia, Heidi“…Although there was a higher number of cesarean section and PROM in the RDS group, but that didn’t reach statistical significance. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3235por Morales-Guerrero, Stephanie Euridice, Rivas-Ortiz, Claudia Ivette, Ponce de León-Rosales, Sergio, Gamboa-Domínguez, Armando, Rangel-Escareño, Claudia, Uscanga-Domínguez, Luis Federico, Aguilar-Gutiérrez, Germán Rubén, Kershenobich-Stalnikowitz, David, Castillo-Rojas, Gonzalo, López-Vidal, Yolanda“…Intestinal metaplasia exhibited an over-expression of gastrointestinal stem cell markers, such as LGR5 and PROM1, as well as messenger RNA and nucleic acid metabolism-related genes. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3236por Hu, Zhenrong, Yang, Ranran, Li, Li, Mao, Lu, Liu, Shuli, Qiao, Shichong, Ren, Guoxin, Hu, Jingzhou“…In the primary tumors, we found that expressions of CSCs markers (ALDH1L1, PECAM1, PROM1) were down-regulated, while immune suppression markers FOXP3, CD47, EGFR, SOX2, and TGFB1 were up-regulated significantly when compared to that in adjacent normal tissues. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3237“…One of the major hurdles hindering the clinical development of PSC-based therapy is the potential risk of tumorigenesis. CD133 (Prominin 1, PROM1) is a transmembrane protein whose mRNA and glycosylated forms are highly expressed in many human cancer cell types. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3238por Vendrik, J., de Boer, J., Zwiers, W., van Gilst, S. A., Holierook, M., Chekanova, E. V., Henriques, J. S., Baan Jr., J.“…The patients had a mean age of 80 ± 5 years and 59% were male, with a predicted surgical risk of 2.2 ± 0.9/3.1 ± 2.4% (Society of Thoracic Surgeons Predicted Risk of Mortality [STS-PROM] score/EuroSCORE II), depicting a contemporary, lower-risk population. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3239por An, Xingyan, Wang, Tong, Zhang, Wei, Yu, Hongliang, Chunhua Zhao, Robert, Guo, Yan, Wang, Chunjiu, Qin, Luxue, Guo, Changqing“…The combination therapy significantly restored the KOA-induced decrease in passive range of motion (PROM) in the knee joint and reduced the elevated serum level of cartilage oligomeric matrix protein (COMP), a marker for cartilage degeneration. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3240por Law, Aaron, Solano, Olubunmi, Brown, Celeste J., Hunter, Samuel S., Fagnan, Matt, Top, Eva M., Stalder, Thibault“…The plasmids belonged to the broad-host-range plasmid (BHR) groups IncP-1 or PromA. Several of them were persistent in their new hosts when grown in the absence of antibiotics, suggesting that the newly acquired drug resistance traits would be sustained over time. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto